Dr. Abdul H. Abbasi, MD

Dr. Abbasi practices at WVU Medicine Uniontown Hospital in Uniontown, Pennsylvania, part of West Virginia University Health System.

Dr. Abbasi's NPI, 1467408864, was assigned on May 26, 2006. Dr. Abbasi holds Pennsylvania license MD430004.

Dr. Abbasi's primary practice is WVU Medicine Uniontown Hospital, at 500 West Berkeley Street, Uniontown, PA 15401 in Fayette County. The practice phone is (724) 430-5000.

Dr. Abbasi's primary practice is WVU Medicine Uniontown Hospital in Uniontown, Pennsylvania, part of West Virginia University Health System. Dr. Abbasi is also affiliated with J.W. Ruby Memorial Hospital. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Abbasi to 2 more hospitals, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abbasi practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Abbasi's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Abbasi's licenses on file in 3 states: Pennsylvania, Maryland and West Virginia.

CMS data shows 842 Medicare services from Dr. Abbasi across 19 procedure codes in 2024, for 545 Medicare patients. Medicare paid $37,203 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 545 Medicare patients who saw Dr. Abbasi in 2024. The largest group is 65 to 74, with 254 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abbasi's median patient age at 69, with 46% women.

In 2024, Dr. Abbasi wrote 281 Medicare Part D claims for 109 patients. 82% of them were for generic drugs. CMS names the drug for 216 of them, across 11 drugs with 11 or more claims each, at $25,212 in total drug cost. In 2023, CMS named 222 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Abbasi for performance year 2024, reported through an alternative payment model (APM). Dr. Abbasi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 171 general payments to Dr. Abbasi from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Pfizer Inc. paid the most, $509.